$ITCI
Intra-Cellular Therapies, Inc.

2014 Q1 Form 10-K Financial Statement

#000119312514114613 Filed on March 25, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2012 Q4 2012
Revenue $167.8K $670.0K $3.118M
YoY Change -71.95% -86.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.910M $1.120M $4.030M
YoY Change 81.9% -12.58%
% of Gross Profit
Research & Development $2.829M $520.0K $15.49M
YoY Change -42.87% 102.44%
% of Gross Profit
Depreciation & Amortization $6.317K $10.00K $47.75K
YoY Change 1.9% -74.87%
% of Gross Profit
Operating Expenses $2.829M $1.640M $15.49M
YoY Change -42.87% 26.21%
Operating Profit -$4.574M -$16.40M
YoY Change -15.3%
Interest Expense $5.041K -$180.0K $193.5K
YoY Change -97.91% 222.5%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.540M -$1.150M -$16.56M
YoY Change -19.5% -248.39%
Income Tax $0.00 $10.00K $32.92K
% Of Pretax Income
Net Earnings -$4.543M -$1.160M -$16.59M
YoY Change -19.42% -249.6%
Net Earnings / Revenue -2707.77% -173.13% -532.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$171.5K -$206.4K -$2.957M
COMMON SHARES
Basic Shares Outstanding 29.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2012 Q4 2012
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.6M $19.10M $19.10M
YoY Change -16.59%
Cash & Equivalents $143.6M $15.65M $15.60M
Short-Term Investments $2.000M $3.500M $3.500M
Other Short-Term Assets $600.0K $200.0K $200.0K
YoY Change 100.0%
Inventory
Prepaid Expenses
Receivables $167.8K $300.4K $300.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $146.4M $19.63M $19.60M
YoY Change -16.24%
LONG-TERM ASSETS
Property, Plant & Equipment $65.08K $58.27K $100.0K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.4K $130.8K $100.0K
YoY Change -50.0%
Total Long-Term Assets $265.5K $189.0K $200.0K
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $146.4M $19.63M $19.60M
Total Long-Term Assets $265.5K $189.0K $200.0K
Total Assets $146.6M $19.82M $19.80M
YoY Change -16.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.143M $41.61K $0.00
YoY Change -100.0%
Accrued Expenses $1.800M $1.100M $1.100M
YoY Change -38.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.912M $2.840M $2.800M
YoY Change -30.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.912M $2.840M $2.800M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.900M $2.800M $2.800M
YoY Change -50.88%
SHAREHOLDERS EQUITY
Retained Earnings -$62.11M -$30.70M
YoY Change
Common Stock $2.922K $1.460K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $142.7M $16.98M $17.00M
YoY Change
Total Liabilities & Shareholders Equity $146.6M $19.82M $19.80M
YoY Change -16.1%

Cashflow Statement

Concept 2014 Q1 2012 Q4 2012
OPERATING ACTIVITIES
Net Income -$4.543M -$1.160M -$16.59M
YoY Change -19.42% -249.6%
Depreciation, Depletion And Amortization $6.317K $10.00K $47.75K
YoY Change 1.9% -74.87%
Cash From Operating Activities -$6.980M -$4.120M -$18.90M
YoY Change -216.67%
INVESTING ACTIVITIES
Capital Expenditures $3.120K $0.00 $38.96K
YoY Change -38.28% -294.79%
Acquisitions
YoY Change
Other Investing Activities $0.00 $750.0K $5.700M
YoY Change -231.03%
Cash From Investing Activities $0.00 $750.0K $5.660M
YoY Change -229.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $116.2M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 115.5M 15.18M 15.19M
YoY Change
NET CHANGE
Cash From Operating Activities -6.980M -4.120M -18.90M
Cash From Investing Activities 0.000 750.0K 5.660M
Cash From Financing Activities 115.5M 15.18M 15.19M
Net Change In Cash 108.5M 11.81M 1.950M
YoY Change -83.52%
FREE CASH FLOW
Cash From Operating Activities -$6.980M -$4.120M -$18.90M
Capital Expenditures $3.120K $0.00 $38.96K
Free Cash Flow -$6.983M -$4.120M -$18.94M
YoY Change -216.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29222746 shares
CY2014Q1 dei Entity Public Float
EntityPublicFloat
389487576
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
17892303
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13693215
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14599612 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14599612 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.3802
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1707114 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3220417
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47678924
CY2012Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
404656
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
41608
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11557988
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2839595
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
16984085
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
726657
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30696299
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1666674
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1460
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19823680
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0
CY2012Q4 us-gaap Assets Current
AssetsCurrent
19634659
CY2012Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
27516
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
282268
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
130755
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8329939
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.9825
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1400125 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.7461
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3232003
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89177556
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2611091
CY2012Q4 us-gaap Assets
Assets
19823680
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15645528
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
215865
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
300429
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3278683
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1928714
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
643669
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
188702
CY2012Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
3500000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58266
CY2012Q4 itci Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
11557988
CY2012Q4 itci Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
-130017
CY2012Q4 itci Deferred Tax Assets Non Qualified Stock Options
DeferredTaxAssetsNonQualifiedStockOptions
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22159446 shares
CY2013Q4 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1182140 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22159446 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.9825
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1400125 shares
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3395067
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24787343
CY2013Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
109834
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6834037
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1715904
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
31615275
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
827879
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57564497
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2216
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38449312
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
616982
CY2013Q4 us-gaap Assets Current
AssetsCurrent
38249485
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
31891
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
377049
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
131555
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22346862
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
27000000
CY2013Q4 us-gaap Assets
Assets
38449312
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35150924
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336318
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3300275
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1874939
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
49300000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
762243
CY2013Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2000000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
467329
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68272
CY2013Q4 itci Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
24787343
CY2013Q4 itci Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
-102916
CY2013Q4 itci Deferred Tax Assets Non Qualified Stock Options
DeferredTaxAssetsNonQualifiedStockOptions
53686
CY2013 dei Entity Registrant Name
EntityRegistrantName
Intra-Cellular Therapies, Inc.
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001567514
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0220 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.800 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17260768 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.2600
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22591265
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
247600 shares
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0007 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.5037 pure
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.26
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.6472
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
40123 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
514466 shares
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Concentration of Credit Risk</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Cash equivalents are held with major financial institutions in the United States. Certificates of deposit held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk.</p> </div>
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0658 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.8479
CY2013 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Deferred Revenue</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Cash received as prepayment on future services is deferred and recognized as revenue as the services are performed. The Company must remit interest on any deferred revenue related to a governmental agency. As of December&#xA0;31, 2013 and 2012, no interest was due as the Company did not have any deferred revenue from a government agency.</p> </div>
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Use of Estimates</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although actual results could differ from those estimates, management does not believe that such differences would be material.</p> </div>
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0372 pure
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3353459
CY2013 us-gaap Revenues
Revenues
2737002
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
574341
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6649
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
278000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
332938
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
31437
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
29617
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-26266852
CY2013 us-gaap Interest Paid
InterestPaid
11320
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-13229355
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1709255
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35889
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-26868198
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
391393
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
200000
CY2013 us-gaap Payments For Repurchase Of Private Placement
PaymentsForRepurchaseOfPrivatePlacement
3754706
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33255
CY2013 us-gaap License And Services Revenue
LicenseAndServicesRevenue
2737002
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
77138
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2785736
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5976276
CY2013 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
43841850
CY2013 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1500000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
40629916
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13229355
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1666674
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
580623
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
391393
CY2013 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
29003854
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19505396
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1466745
CY2013 us-gaap Interest Expense
InterestExpense
612963
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23027578
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
332938
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18000
CY2013 us-gaap Depreciation
Depreciation
23249
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
827479
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2013 itci Percentage Of Dividend Rate
PercentageOfDividendRate
0.00 pure
CY2013 itci Federal Net Operating Loss Carry Forward Expiration Period
FederalNetOperatingLossCarryForwardExpirationPeriod
2034
CY2013 itci Proceeds From Common Stock Subscribed
ProceedsFromCommonStockSubscribed
109834
CY2013 itci Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm
P2Y3M18D
CY2013 itci Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2013 itci Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0120 pure
CY2013 itci Certificates Of Deposit Maturity Period
CertificatesOfDepositMaturityPeriod
More than three months
CY2013 itci Maturity Period Of Liquid Investments To Be Considered As Cash Equivalents
MaturityPeriodOfLiquidInvestmentsToBeConsideredAsCashEquivalents
Three months or less
CY2013 itci Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
701723
CY2013 itci Share Based Compensation Arrangement By Share Based Payment Award Canceled Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceledWeightedAverageRemainingContractualTerm
P8Y9M18D
CY2013 itci Stock Issued During Period Value Issuance Of Common Stock Upon Private Placement
StockIssuedDuringPeriodValueIssuanceOfCommonStockUponPrivatePlacement
39963500
CY2013 itci Effective Income Tax Rate Reconciliation Return To Provision Research And Development Tax Credit Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionResearchAndDevelopmentTaxCreditPercent
0.0261 pure
CY2013 itci Effective Income Tax Rate Reconciliation Reserve For Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationReserveForUncertainTaxPositions
-0.0653 pure
CY2013 itci Effective Income Tax Rate Reconciliation State Income Tax Expense
EffectiveIncomeTaxRateReconciliationStateIncomeTaxExpense
0.1012 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0120 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.797 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0020 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3984 pure
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5607539 shares
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18902937
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.96
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2012 us-gaap Revenues
Revenues
3117991
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34189
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
332000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31081
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
13857
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
39002
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-16403410
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
12000000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-6289888
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-48634
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-16590827
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
295106
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38957
CY2012 us-gaap License And Services Revenue
LicenseAndServicesRevenue
3117991
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
79656
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-448493
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4034925
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
17700122
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15194085
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6289888
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1666659
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
295106
CY2012 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
19521401
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1952313
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5661165
CY2012 us-gaap Interest Expense
InterestExpense
193498
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-554256
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15486476
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31081
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
32921
CY2012 us-gaap Depreciation
Depreciation
47747
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
809332
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15163004
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32921
CY2012 itci Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0061 pure
CY2012 itci Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
15356422
CY2012 itci Effective Income Tax Rate Reconciliation Return To Provision Research And Development Tax Credit Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionResearchAndDevelopmentTaxCreditPercent
0.0191 pure
CY2012 itci Effective Income Tax Rate Reconciliation State Income Tax Expense
EffectiveIncomeTaxRateReconciliationStateIncomeTaxExpense
0.0434 pure

Files In Submission

Name View Source Status
0001193125-14-114613-index-headers.html Edgar Link pending
0001193125-14-114613-index.html Edgar Link pending
0001193125-14-114613.txt Edgar Link pending
0001193125-14-114613-xbrl.zip Edgar Link pending
d675342d10k.htm Edgar Link pending
d675342dex1014.htm Edgar Link pending
d675342dex1019.htm Edgar Link pending
d675342dex108.htm Edgar Link pending
d675342dex231.htm Edgar Link pending
d675342dex311.htm Edgar Link pending
d675342dex312.htm Edgar Link pending
d675342dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g675342g08r20.jpg Edgar Link pending
g675342g81n28.jpg Edgar Link pending
itci-20131231.xml Edgar Link completed
itci-20131231.xsd Edgar Link pending
itci-20131231_cal.xml Edgar Link unprocessable
itci-20131231_def.xml Edgar Link unprocessable
itci-20131231_lab.xml Edgar Link unprocessable
itci-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending